UnitedHealth Group Inc (UNH) Stake Increased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. grew its holdings in UnitedHealth Group Inc (NYSE:UNH) by 12.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 498,364 shares of the healthcare conglomerate’s stock after buying an additional 54,474 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.05% of UnitedHealth Group worth $132,584,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Middleton & Co Inc MA boosted its stake in shares of UnitedHealth Group by 17.4% in the third quarter. Middleton & Co Inc MA now owns 31,676 shares of the healthcare conglomerate’s stock worth $8,427,000 after acquiring an additional 4,703 shares during the last quarter. CFO4Life Group LLC boosted its stake in shares of UnitedHealth Group by 90.4% in the third quarter. CFO4Life Group LLC now owns 4,218 shares of the healthcare conglomerate’s stock worth $1,122,000 after acquiring an additional 2,003 shares during the last quarter. Mycio Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the third quarter worth approximately $214,000. First Trust Advisors LP boosted its stake in shares of UnitedHealth Group by 21.4% in the third quarter. First Trust Advisors LP now owns 307,144 shares of the healthcare conglomerate’s stock worth $81,713,000 after acquiring an additional 54,187 shares during the last quarter. Finally, Wright Investors Service Inc. boosted its stake in shares of UnitedHealth Group by 3.2% in the third quarter. Wright Investors Service Inc. now owns 25,295 shares of the healthcare conglomerate’s stock worth $6,729,000 after acquiring an additional 786 shares during the last quarter. Institutional investors and hedge funds own 85.44% of the company’s stock.

In other news, Director William C. Ballard, Jr. sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total value of $2,588,300.00. Following the transaction, the director now owns 77,172 shares of the company’s stock, valued at approximately $19,974,428.76. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,568 shares of company stock worth $24,950,027. Corporate insiders own 0.87% of the company’s stock.

A number of analysts have recently issued reports on the company. BMO Capital Markets lifted their price target on UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research note on Thursday, October 18th. Goldman Sachs Group reaffirmed a “buy” rating and issued a $277.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 17th. Piper Jaffray Companies lifted their price target on UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 17th. Royal Bank of Canada lifted their price target on UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research note on Wednesday, July 18th. Finally, Raymond James lifted their price target on UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a research note on Wednesday, October 17th. One equities research analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $289.41.

NYSE UNH opened at $256.52 on Tuesday. The firm has a market cap of $248.49 billion, a price-to-earnings ratio of 25.47, a P/E/G ratio of 1.49 and a beta of 0.73. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a fifty-two week low of $207.80 and a fifty-two week high of $272.81.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The firm’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.66 earnings per share. Equities analysts anticipate that UnitedHealth Group Inc will post 12.81 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Momentum Indicator: Relative Strength Index

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply